Compare Novo Nordisk A/S (NVO) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Occidental Petroleum Corporation — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Occidental Petroleum Corporation trades at $56.4 (market cap $54.89B). The key difference: Novo Nordisk A/S is far larger — about 4× Occidental Petroleum Corporation's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | OXY | |
|---|---|---|
Market Cap | $220.53B | $54.89B |
Sector | Health | Energy |
52-Week High | $71.70 | $66.24 |
52-Week Low | $35.29 | $38.92 |
Enterprise Value | $239.49B | $75.98B |
Dividend Yield | 3.63% | 1.88% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
